IRCT2017073035382N1招募中3 期
Evaluation of local Deferoxamine impact on revascularization and improvement of avascular necrosis of the lunate bone (Kienbock's disease)
Vice Chancellor for research of Iran University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 70 years（—）
- 性别
- All
入选标准
- •Radiologic Diagnosis of the Kienbock's disease by 3 hand surgeons; Age of 18 to 60 years. Lack of hematologic disorders and any disease with platelet Dysfunction; Lack of any comorbid disorders that might increase the risk of surgery including uncontrolled diabetes, cardiovascular disorders, rheumatic diseases such as rheumatoid arthritis, cancers, hepatic and renal failure and etc; Consumption of no drug which affect bone restoration such as corticosteroids.
排除标准
- •New severe trauma affecting the fracture dislocation and fixation status, Incidence of severe infection which can not be controlled with antibiotics and needs surgery; Incidence of disorders needing specific drugs such as corticosteroids and chemotherapy which affect the bone repair.
研究者
相似试验
已完成
2 期
Effect of deferoxamin on strokeCondition 1: stroke. Condition 2: intracerebral haemorrhage.Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesSequelae of intracerebral haemorrhageIRCT2013111915444N2Vice chancellor for research, Ahvaz Jondishapur University of Medical Sciences64
尚未招募
2 期
Deferoxamine on neurological and radiological implications for cerebral hemorrhagelevel of consciousness.Other coma, without documented Glasgow coma scale score, or with partial score reportedR40.244IRCT20190325043107N30Tabriz University of Medical Sciences42
尚未招募
2 期
Efficacy and safety of triple iron chelator (deferoxamine, deferasirox, and deferiprone) versus dual iron chelator (deferoxamine and deferasirox) combination therapy for reducing iron overload in transfusion-dependent beta-thalassaemia with very high iron overload.ThalassaemiaSLCTR/2023/010Prof Anuja Premawardhena
招募中
3 期
Deferoxamine in severe traumatic brain injuryIRCT20220220054079N1Shiraz University of Medical Sciences68
Unknown
1 期
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectableNCT03652467Jinan Military General Hospital100